H1 receptor antagonists significantly improved overall survival rates and suppressed tumor growth as well as the infiltration of mast cells and VEGF levels through the inhibition of HIF-1α expression in B16F10 melanoma-bearing mice (41). This evidence concerns the gene VEGFA and melanoma.